This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| Health | 267 |
| H1N1 | 195 |
| United | 164 |
| States | 152 |
| MS | 140 |
| MMR | 140 |
| Influenza | 136 |
| Immunization | 136 |
| B | 134 |
| Vaccine | 113 |
| National | 110 |
| Table | 92 |
| Disease | 90 |
| Vaccination | 90 |
| pH1N1 | 89 |
| BCG | 87 |
| US | 85 |
| HCWs | 85 |
| NS | 82 |
| MDA | 79 |
| ITP | 78 |
| T | 77 |
| HCW | 73 |
| COVID-19 | 73 |
| Control | 72 |
| Committee | 72 |
| A | 72 |
| Prevention | 71 |
| New | 70 |
| SARS | 69 |
| Africa | 69 |
| Australia | 68 |
| Hong | 65 |
| Kong | 64 |
| World | 62 |
| Europe | 59 |
| HPV | 57 |
| Korea | 56 |
| Advisory | 56 |
| CI | 55 |
| II | 50 |
| Institute | 50 |
| ⁄ | 50 |
| hepatitis | 49 |
| MLV | 47 |
| FMD | 47 |
| • | 46 |
| Fig | 45 |
| sha | 44 |
| Social | 44 |
| Department | 44 |
| Vaccines | 43 |
| DOI | 43 |
| China | 43 |
| Diseases | 42 |
| Zealand | 41 |
| U.S. | 41 |
| CDV | 41 |
| Public | 40 |
| Organization | 40 |
| CDC | 40 |
| CAV | 40 |
| RA | 39 |
| Israel | 39 |
| HBV | 39 |
| Shanghai | 38 |
| Mumps | 38 |
| Program | 37 |
| Safety | 37 |
| USA | 37 |
| Ministry | 36 |
| Human | 36 |
| Association | 36 |
| Research | 35 |
| Medical | 35 |
| Japan | 35 |
| IgG | 35 |
| ICP | 35 |
| CoV-2 | 35 |
| American | 35 |
| ACIP | 34 |
| Infectious | 34 |
| Measles | 34 |
| Practices | 34 |
| South | 33 |
| IgM | 33 |
| Centers | 33 |
| America | 33 |
| Pasteur | 32 |
| NALT | 32 |
| System | 31 |
| MuV | 31 |
| C | 31 |
| Group | 30 |
| Center | 30 |
| Germany | 30 |
| R | 30 |
| Lkt | 30 |
| UK | 30 |
| WHO | 30 |
| PCR | 29 |
| European | 29 |
| Care | 29 |
| CD4 | 29 |
| ASIA | 29 |
| Hib | 28 |
| Appendix | 28 |
| CPV | 28 |
| France | 28 |
| Hospital | 28 |
| J | 28 |
| Services | 28 |
| eff | 28 |
| T2DM | 27 |
| Rabies | 27 |
| RNA | 27 |
| Italy | 27 |
| FDA | 27 |
| Canada | 27 |
| ADEM | 27 |
| IHNV | 26 |
| DM | 26 |
| University | 26 |
| β | 26 |
| TPB | 25 |
| January | 25 |
| I | 25 |
| Feline | 25 |
| Centre | 25 |
| M. | 24 |
| England | 24 |
| File | 24 |
| Information | 24 |
| Development | 24 |
| Medicine | 24 |
| Review | 24 |
| Survey | 24 |
| ∞ | 24 |
| VGG | 23 |
| State | 23 |
| SIR | 23 |
| S2 | 23 |
| HIV | 23 |
| General | 23 |
| FIV | 23 |
| CD8 | 22 |
| Jenner | 22 |
| Law | 22 |
| Practice | 22 |
| Smallpox | 22 |
| Tanzania | 22 |
| Veterinary | 22 |
| chi | 22 |
| imm | 21 |
| i.m | 21 |
| OPV | 21 |
| May | 21 |
| Administration | 21 |
| IPV | 20 |
| Animal | 20 |
| Ebola | 20 |
| Evaluation | 20 |
| Healthcare | 20 |
| July | 20 |
| R. | 20 |
| IgA | 20 |
| Western | 20 |
| mg | 20 |
| Kingdom | 20 |
| ‹ | 20 |
| ≥10 | 19 |
| Report | 19 |
| Hepatitis | 19 |
| Dr. | 19 |
| Asia | 18 |
| Australian | 18 |
| California | 18 |
| ELISA | 18 |
| Foundation | 18 |
| HCP | 18 |
| IN | 18 |
| Pandemic | 18 |
| Polio | 18 |
| Science | 18 |
| Ireland | 18 |
| Global | 17 |
| Britain | 17 |
| Children | 17 |
| Commission | 17 |
| Force | 17 |
| International | 17 |
| Reporting | 17 |
| Task | 17 |
| haemolytica | 17 |
| Spain | 17 |
| India | 16 |
| April | 16 |
| Council | 16 |
| DTP | 16 |
| Denmark | 16 |
| Great | 16 |
| HC | 16 |
| HLA | 16 |
| JL | 16 |
| Laboratory | 16 |
| March | 16 |
| McNemar | 16 |
| School | 16 |
| TT | 16 |
| Thailand | 16 |
| Use | 16 |
| FeLV | 15 |
| Government | 15 |
| Management | 15 |
| FIP | 15 |
| Brazil | 15 |
| June | 15 |
| FHV | 15 |
| Seasonal | 15 |
| Strategies | 15 |
| VZV | 15 |
| meta | 15 |
| calicivirus | 15 |
| Society | 15 |
| Protection | 14 |
| August | 14 |
| Cross | 14 |
| Eq | 14 |
| Food | 14 |
| Guidelines | 14 |
| Netherlands | 14 |
| North | 14 |
| October | 14 |
| Mucosal | 14 |
| Push | 14 |
| Surveillance | 14 |
| Tdap | 14 |
| UNICEF | 14 |
| War | 14 |
| York | 14 |
| association | 14 |
| fingolimod | 14 |
| Routine | 14 |
| Court | 13 |
| FECV | 13 |
| Effectiveness | 13 |
| December | 13 |
| Database | 13 |
| Data | 13 |
| Academy | 13 |
| Calmette | 13 |
| CNS | 13 |
| Bordetella | 13 |
| AE | 13 |
| IB | 13 |
| Figure | 13 |
| Americans | 13 |
| Inc. | 13 |
| SB | 13 |
| bronchiseptica | 13 |
| Study | 13 |
| trout | 13 |
| SPSS | 13 |
| SED | 13 |
| Isr | 13 |
| Pull | 13 |
| MHC | 13 |
| K | 13 |
| John | 13 |
| J. | 13 |
| OR | 13 |
| Ethics | 12 |
| IV | 12 |
| ID | 12 |
| HI | 12 |
| GPs | 12 |
| Framework | 12 |
| Finland | 12 |
| Canine | 12 |
| Community | 12 |
| Child | 12 |
| COPD | 12 |
| CC | 12 |
| Board | 12 |
| Joint | 12 |
| AIDS | 12 |
| Immunisation | 12 |
| Leask | 12 |
| Pneumococcal | 12 |
| Legal | 12 |
| ≥50 | 12 |
| VPD | 12 |
| September | 12 |
| Risk | 12 |
| Policy | 12 |
| SLE | 12 |
| Pediatric | 12 |
| Panel | 12 |
| Oncorhynchus | 12 |
| ND | 12 |
| NC | 12 |
| M | 12 |
| Greece | 11 |
| NIH | 11 |
| MVA | 11 |
| Lee | 11 |
| Justice | 11 |
| Journal | 11 |
| Immunogenicity | 11 |
| AH | 11 |
| Fisher | 11 |
| FHMC | 11 |
| E. | 11 |
| Drug | 11 |
| Network | 11 |
| Biography | 11 |
| Analysis | 11 |
| NSW | 11 |
| Ciotti | 11 |
| Nevo | 11 |
| Valtcheva | 11 |
| γ | 11 |
| uenza | 11 |
| parainfluenza | 11 |
| kg | 11 |
| ective | 11 |
| benefi | 11 |
| November | 11 |
| Turkey | 11 |
| TM | 11 |
| S | 11 |
| Regional | 11 |
| Pharmacy | 11 |
| POD | 11 |
| Theory | 11 |
| DTaP | 10 |
| Jeryl | 10 |
| JR | 10 |
| Haemophilus | 10 |
| Francis | 10 |
| FCV | 10 |
| Epstein | 10 |
| Epidemiology | 10 |
| C. | 10 |
| Cronbach | 10 |
| Chapter | 10 |
| Black | 10 |
| Barr | 10 |
| Assessment | 10 |
| Antibody | 10 |
| Knowledge | 10 |
| Kittens | 10 |
| Healthy | 10 |
| L. | 10 |
| Puppies | 10 |
| Life | 10 |
| Workers | 10 |
| West | 10 |
| YF | 10 |
| Wakefield | 10 |
| Union | 10 |
| Summary | 10 |
| Wales | 10 |
| Oregon | 10 |
| Multiple | 10 |
| Mexico | 10 |
| MV | 10 |
| Lynn | 10 |
| NIS | 10 |
| Lkt50 | 10 |
| Coronavirus | 9 |
| Chinese | 9 |
| Chronic | 9 |
| City | 9 |
| College | 9 |
| Education | 9 |
| DALY | 9 |
| Efficacy | 9 |
| Emergency | 9 |
| Event | 9 |
| Childhood | 9 |
| Affairs | 9 |
| Chapman | 9 |
| Canis | 9 |
| CCI | 9 |
| British | 9 |
| BY | 9 |
| BPharm | 9 |
| Agency | 9 |
| Act | 9 |
| APS | 9 |
| AA | 9 |
| FITC | 9 |
| F | 9 |
| NE | 9 |
| Guide | 9 |
| NVAC | 9 |
| Gulf | 9 |
| siponimod | 9 |
| Working | 9 |
| Service | 9 |
| Sciences | 9 |
| SRNS | 9 |
| Practitioners | 9 |
| Physicians | 9 |
| People | 9 |
| PSL | 9 |
| Preventive | 9 |
| Microsoft | 9 |
| Initiative | 9 |
| Merck | 9 |
| H5N1 | 9 |
| IFN | 9 |
| Immune | 9 |
| H3N2 | 9 |
| Koch | 9 |
| Laboratories | 9 |
| Lyme | 9 |
| MMWR | 9 |
| Communication | 8 |
| Immunother | 8 |
| ISCOM | 8 |
| I. | 8 |
| Hum | 8 |
| Geneva | 8 |
| East | 8 |
| EPI | 8 |
| EK | 8 |
| DC | 8 |
| Country | 8 |
| Con | 8 |
| Lancet | 8 |
| Clinical | 8 |
| Change | 8 |
| Biologics | 8 |
| Benjamin | 8 |
| Behavior | 8 |
| Bacille | 8 |
| BP | 8 |
| Associated | 8 |
| Adverse | 8 |
| Adalah | 8 |
| < | 8 |
| Impact | 8 |
| Nurses | 8 |
| Louis | 8 |
| Pediatrics | 8 |
| Ltd | 8 |
| antigen | 8 |
| Virus | 8 |
| Switzerland | 8 |
| Seoul | 8 |
| Salk | 8 |
| S. | 8 |
| Predictors | 8 |
| Philadelphia | 8 |
| Pharmaceutical | 8 |
| Supreme | 8 |
| Paulo | 8 |
| Office | 8 |
| PCV13 | 8 |
| Marketing | 8 |
| Merial | 8 |
| ects | 8 |
| Northern | 8 |
| Ontario | 8 |
| Outbreaks | 8 |
| PBC | 8 |
| PBS | 8 |
| Guerin | 7 |
| Joseon | 7 |
| Guillain | 7 |
| HCJ | 7 |
| IFA | 7 |
| Infection | 7 |
| Institutes | 7 |
| Methisazone | 7 |
| London | 7 |
| ML | 7 |
| MPharm | 7 |
| MR | 7 |
| Mannheimia | 7 |
| Middle | 7 |
| GBS | 7 |
| GP | 7 |
| Basic | 7 |
| G | 7 |
| CBA | 7 |
| Agriculture | 7 |
| Annual | 7 |
| B. | 7 |
| BMI | 7 |
| Morbidity | 7 |
| Behring | 7 |
| CPV2 | 7 |
| Form | 7 |
| CPV2b | 7 |
| Central | 7 |
| Coverage | 7 |
| D. | 7 |
| FMS | 7 |
| Flu | 7 |
| Model | 7 |
| IIM | 7 |
| NV | 7 |
| Standards | 7 |
| Trends | 7 |
| Windows | 7 |
| das | 7 |
| defensin | 7 |
| doc_id | 7 |
| eq | 7 |
| group | 7 |
| pandemic | 7 |
| sera | 7 |
| ts | 7 |
| ε | 7 |
| π | 7 |
| − | 7 |
| ≤ | 7 |
| Optimal | 7 |
| Thomas | 7 |
| panleukopenia | 7 |
| Singapore | 7 |
| Project | 7 |
| PPSV23 | 7 |
| Shih | 7 |
| PV | 7 |
| Patient | 7 |
| Populations | 7 |
| Post | 7 |
| Paul | 7 |
| Quarantine | 7 |
| RV | 7 |
| Region | 7 |
| Richard | 7 |
| Quality | 7 |
| Republic | 7 |
| GMT | 6 |
| IL-7 | 6 |
| K. | 6 |
| IMHA | 6 |
| ILI | 6 |
| Guérin | 6 |
| Henoch | 6 |
| Gostin | 6 |
| KLH | 6 |
| Freund | 6 |
| KAP | 6 |
| Ltd. | 6 |
| Kansas | 6 |
| L | 6 |
| Leptospira | 6 |
| Liberty | 6 |
| Los | 6 |
| MEPS | 6 |
| MHLC | 6 |
| MMF | 6 |
| Excel | 6 |
| Molecular | 6 |
| Fort | 6 |
| Americas | 6 |
| Elsevier | 6 |
| Edward | 6 |
| Nicholls | 6 |
| 8) | 6 |
| AAFP | 6 |
| AI | 6 |
| ASP | 6 |
| Action | 6 |
| Alaska | 6 |
| Autoimmune | 6 |
| Bangkok | 6 |
| Behavioral | 6 |
| Behaviour | 6 |
| Briggs | 6 |
| CD | 6 |
| CPV-2 | 6 |
| Canberra | 6 |
| Chlamydia | 6 |
| Clin | 6 |
| CoV | 6 |
| Covid-19 | 6 |
| CpG | 6 |
| Duluth | 6 |
| Mycobacterium | 6 |
| Rachaniotis | 6 |
| No | 6 |
| Tetanus | 6 |
| Travel | 6 |
| USDA | 6 |
| VAERS | 6 |
| VHSV | 6 |
| Warp | 6 |
| Washington | 6 |
| Welfare | 6 |
| aL | 6 |
| aff | 6 |
| antiphospholipid | 6 |
| covid-19 | 6 |
| herpes | 6 |
| il7r | 6 |
| mumps | 6 |
| nan | 6 |
| natalizumab | 6 |
| pemphigoid | 6 |
| poxvirus | 6 |
| vaccination | 6 |
| Operation | 6 |
| ± | 6 |
| Therapeutic | 6 |
| influenza | 6 |
| Technology | 6 |
| Resources | 6 |
| Outbreak | 6 |
| Systematic | 6 |
| Organisation | 6 |
| P=0 | 6 |
| PCV7 | 6 |
| PPV23 | 6 |
| PWMS | 6 |
| Programme | 6 |
| RT | 6 |
| PMR | 6 |
| Robert | 6 |
| Schedule | 6 |
| Spier | 6 |
| Speed | 6 |
| Security | 6 |
| Scientific | 6 |
| Small | 6 |
| SAS | 6 |
| Rubella | 6 |
| Sarcoma | 6 |
| HBM | 5 |
| Fc | 5 |
| GlaxoSmithKline | 5 |
| Georgia | 5 |
| Franklin | 5 |
| Fever | 5 |
| February | 5 |
| Embase | 5 |
| Family | 5 |
| Factors | 5 |
| FES | 5 |
| District | 5 |
| Erez | 5 |
| Enders | 5 |
| Employee | 5 |
| H | 5 |
| Insights | 5 |
| HN | 5 |
| Jab | 5 |
| Maternal | 5 |
| Detection | 5 |
| Massachusetts | 5 |
| Literature | 5 |
| Likert | 5 |
| Joanna | 5 |
| Iowa | 5 |
| Handbook | 5 |
| Infections | 5 |
| Induction | 5 |
| Indian | 5 |
| Immunology | 5 |
| Hodgins | 5 |
| Hilleman | 5 |
| Diabetes | 5 |
| Aujeszky | 5 |
| Design | 5 |
| Am | 5 |
| Barak | 5 |
| Bangladesh | 5 |
| Attitudes | 5 |
| Arbel | 5 |
| Arabia | 5 |
| Angeles | 5 |
| Alzheimer | 5 |
| Davis | 5 |
| Agents | 5 |
| African | 5 |
| Adalla | 5 |
| ATCC | 5 |
| AAP | 5 |
| MenB | 5 |
| Belgium | 5 |
| Borrelia | 5 |
| Branch | 5 |
| Brasil | 5 |
| CAV-1 | 5 |
| CFS | 5 |
| Canadian | 5 |
| Carter | 5 |
| Clear | 5 |
| Communicable | 5 |
| Comptroller | 5 |
| D | 5 |
| DFA | 5 |
| DMT | 5 |
| DQB1 | 5 |
| DRB1 | 5 |
| Datalink | 5 |
| Medicines | 5 |
| Times | 5 |
| Meta | 5 |
| Urabe | 5 |
| Wang | 5 |
| WSAVA | 5 |
| Viral | 5 |
| Varicella | 5 |
| Vaccinomics | 5 |
| V. | 5 |
| UCTD | 5 |
| Years | 5 |
| Tuftsin | 5 |
| Thrombocytopenia | 5 |
| Territory | 5 |
| Technical | 5 |
| Team | 5 |
| Taiwan | 5 |
| Wurzler | 5 |
| Zimbabwe | 5 |
| São | 5 |
| s.c | 5 |
| Mill | 5 |
| ‡65 | 5 |
| ρ | 5 |
| van | 5 |
| tuftsin | 5 |
| tnfa | 5 |
| rabies | 5 |
| a1111111111 | 5 |
| ocrelizumab | 5 |
| le | 5 |
| el | 5 |
| dpv | 5 |
| diff | 5 |
| aOR | 5 |
| TLRs | 5 |
| mitogens | 5 |
| Systems | 5 |
| Pharmacist | 5 |
| Profiles | 5 |
| Professionals | 5 |
| Planning | 5 |
| Planned | 5 |
| Plan | 5 |
| Philippe | 5 |
| Pearson | 5 |
| Rates | 5 |
| Pandemrix | 5 |
| PHA | 5 |
| Overview | 5 |
| Ordinance | 5 |
| Syst | 5 |
| Monitoring | 5 |
| Programs | 5 |
| PPV | 5 |
| Recommendations | 5 |
| Shewen | 5 |
| Swine | 5 |
| Respiratory | 5 |
| Syndrome | 5 |
| Studies | 5 |
| Statistical | 5 |
| Springs | 5 |
| Streptococcus | 5 |
| Serengeti | 5 |
| Salmonella | 5 |
| SD | 5 |
| Schönlein | 5 |
| Sabin | 5 |
| Sclerosis | 5 |
| Flushing | 4 |
| Foods | 4 |
| GWS | 4 |
| HAV | 4 |
| Gebhard | 4 |
| HHS | 4 |
| Hajj | 4 |
| Finlay | 4 |
| Helsinki | 4 |
| Harrison | 4 |
| Fish | 4 |
| Effective | 4 |
| 4 | |
| Expert | 4 |
| Expanded | 4 |
| English | 4 |
| Emil | 4 |
| Effect | 4 |
| EMA | 4 |
| EIR | 4 |
| ECOM | 4 |
| ECDC | 4 |
| Herpes | 4 |
| E | 4 |
| HepA | 4 |
| Jacobson | 4 |
| Hesitancy | 4 |
| JL2 | 4 |
| Dr | 4 |
| Meeting | 4 |
| Mandatory | 4 |
| MPLA | 4 |
| MPL | 4 |
| MERS | 4 |
| Les | 4 |
| Lady | 4 |
| King | 4 |
| K.N. | 4 |
| Investigation | 4 |
| High | 4 |
| Intranasal | 4 |
| Interview | 4 |
| Insurance | 4 |
| Institutional | 4 |
| Indonesia | 4 |
| Individual | 4 |
| Immunol | 4 |
| IDSA | 4 |
| ICS | 4 |
| Hiroshi | 4 |
| Dynasty | 4 |
| Bacillus | 4 |
| Dog | 4 |
| Dodge | 4 |
| Biological | 4 |
| Biologic | 4 |
| Bethyl | 4 |
| Beijing | 4 |
| Basel | 4 |
| Barre | 4 |
| BIC | 4 |
| Assembly | 4 |
| Area | 4 |
| Anti | 4 |
| Ankara | 4 |
| Allocation | 4 |
| Adults | 4 |
| Adolescent | 4 |
| Adjusted | 4 |
| Acceptance | 4 |
| AS03 | 4 |
| APC | 4 |
| A1 | 4 |
| A. | 4 |
| A(H1N1 | 4 |
| -Persons | 4 |
| Montague | 4 |
| Biosystems | 4 |
| Brucella | 4 |
| Burden | 4 |
| Congress | 4 |
| Discrete | 4 |
| Director | 4 |
| Dignity | 4 |
| Deterministic | 4 |
| Defense | 4 |
| DOD | 4 |
| DNA | 4 |
| DH | 4 |
| Corporation | 4 |
| Coronaviridae | 4 |
| Complications | 4 |
| CCVB | 4 |
| Comparative | 4 |
| Cohen | 4 |
| Co. | 4 |
| Clinicas | 4 |
| Cidofovir | 4 |
| Charlson | 4 |
| Case | 4 |
| Carlo | 4 |
| COVID | 4 |
| CII | 4 |
| Methods | 4 |
| OSCA | 4 |
| NGO | 4 |
| Support | 4 |
| Young | 4 |
| Yellow | 4 |
| Wyeth | 4 |
| Women | 4 |
| White | 4 |
| Waterhouse | 4 |
| Victoria | 4 |
| Vibrio | 4 |
| Vaccinations | 4 |
| VICP | 4 |
| V | 4 |
| Uptake | 4 |
| Type | 4 |
| 4 | |
| Trust | 4 |
| Trump | 4 |
| Transmission | 4 |
| Toronto | 4 |
| Theptarin | 4 |
| Tanimoto | 4 |
| Tab | 4 |
| TLR | 4 |
| TBP | 4 |
| bacille | 4 |
| bacterin | 4 |
| blastogenic | 4 |
| mRNA | 4 |
| NHS | 4 |
| | | 4 |
| zoster | 4 |
| tTG | 4 |
| polyarthritis | 4 |
| pg | 4 |
| pancytopenia | 4 |
| morbillivirus | 4 |
| methisazone | 4 |
| max | 4 |
| il1b | 4 |
| calmette | 4 |
| health | 4 |
| guérin | 4 |
| glatiramer | 4 |
| fumarate | 4 |
| france | 4 |
| effi | 4 |
| disease | 4 |
| des | 4 |
| cytomegalovirus | 4 |
| costeff | 4 |
| T. | 4 |
| measles | 4 |
| Supplementary | 4 |
| Pappis | 4 |
| Press | 4 |
| Presponse | 4 |
| Poisson | 4 |
| Philo | 4 |
| Phillips | 4 |
| Peyer | 4 |
| Peter | 4 |
| Personnel | 4 |
| Persian | 4 |
| Part | 4 |
| PSA | 4 |
| Product | 4 |
| PS | 4 |
| PM | 4 |
| PLoS | 4 |
| PCV2 | 4 |
| P.A. | 4 |
| × | 4 |
| Norway | 4 |
| News | 4 |
| Nash | 4 |
| Suk | 4 |
| Prism | 4 |
| P. | 4 |
| Products | 4 |
| Saharan | 4 |
| Stephen | 4 |
| Station | 4 |
| Promotion | 4 |
| Standard | 4 |
| Schultz | 4 |
| Scheduling | 4 |
| Saunders | 4 |
| Saudi | 4 |
| Sars | 4 |
| Sanofi | 4 |
| Shoenfeld | 4 |
| SSNS | 4 |
| Prophylaxis | 4 |
| SIRV | 4 |
| PubMed | 4 |
| Quil | 4 |
| Rapid | 4 |
| QALY | 4 |
| Reed | 4 |
| Regulations | 4 |
| Response | 4 |
| Rural | 4 |
| Gross | 3 |
| GEE | 3 |
| Gardasil | 3 |
| Genome | 3 |
| GAVI | 3 |
| George | 3 |
| Governor | 3 |
| GDP | 3 |
| Happer | 3 |
| H. | 3 |
| HAI | 3 |
| HSP | 3 |
| Harris | 3 |
| Helicobacter | 3 |
| Hemisphere | 3 |
| Hep | 3 |
| G. | 3 |
| HepB | 3 |
| Herald | 3 |
| GA | 3 |
| FRNS | 3 |
| Fund | 3 |
| Engagement | 3 |
| ED | 3 |
| Host | 3 |
| EU | 3 |
| EULAR | 3 |
| Effects | 3 |
| El | 3 |
| Elimination | 3 |
| Eng | 3 |
| Eradication | 3 |
| Fu | 3 |
| FPV | 3 |
| FTR | 3 |
| Federal | 3 |
| Federation | 3 |
| Fermi | 3 |
| French | 3 |
| Frequency | 3 |
| Front | 3 |
| Holm | 3 |
| Kawasaki | 3 |
| I(2 | 3 |
| Local | 3 |
| Katoh | 3 |
| Kitasato | 3 |
| Kitching | 3 |
| Korean | 3 |
| L.D. | 3 |
| L.O. | 3 |
| L.v | 3 |
| Limitation | 3 |
| Louise | 3 |
| III | 3 |
| Lycaon | 3 |
| MBP | 3 |
| MF59 | 3 |
| MLL | 3 |
| MRF | 3 |
| MacIntyre | 3 |
| Manufactory | 3 |
| Domestic | 3 |
| Kabir | 3 |
| K.K. | 3 |
| Jun | 3 |
| Jee | 3 |
| IL | 3 |
| IL-18 | 3 |
| Ibaraki | 3 |
| Iceland | 3 |
| Immunity | 3 |
| Index | 3 |
| Injury | 3 |
| Inspection | 3 |
| Internal | 3 |
| Internet | 3 |
| Intervention | 3 |
| Island | 3 |
| Israeli | 3 |
| JBI | 3 |
| JH | 3 |
| James | 3 |
| Japanese | 3 |
| EBV | 3 |
| B19 | 3 |
| Division | 3 |
| Austria | 3 |
| Anim | 3 |
| Animals | 3 |
| Anna | 3 |
| Antiviral | 3 |
| Appropriate | 3 |
| Assistance | 3 |
| Atlanta | 3 |
| Attribution | 3 |
| Authority | 3 |
| Beutels | 3 |
| Autism | 3 |
| Aventis | 3 |
| Master | 3 |
| BACKGROUND | 3 |
| BBB | 3 |
| BMC | 3 |
| Barré | 3 |
| Based | 3 |
| Andrew | 3 |
| Ando | 3 |
| Aluminum | 3 |
| Alexander | 3 |
| -Teen | 3 |
| 19F | 3 |
| 7.1±1.3 | 3 |
| A.D. | 3 |
| A1C | 3 |
| AAHA | 3 |
| ACT | 3 |
| AGPN | 3 |
| AHD | 3 |
| AVMA | 3 |
| Abstract | 3 |
| Access | 3 |
| Accreditation | 3 |
| Adenovirus | 3 |
| Advax | 3 |
| Age | 3 |
| Albert | 3 |
| Behavioural | 3 |
| Bill | 3 |
| Disability | 3 |
| Cr | 3 |
| Clause | 3 |
| Commons | 3 |
| Comorbidity | 3 |
| Comprehensive | 3 |
| Comrie | 3 |
| Conference | 3 |
| Connell | 3 |
| Cost | 3 |
| Creative | 3 |
| Biotech | 3 |
| Crisis | 3 |
| Current | 3 |
| Cutter | 3 |
| DS | 3 |
| Declaration | 3 |
| Dengue | 3 |
| Diamondback | 3 |
| Dis | 3 |
| Civil | 3 |
| Chlamydophila | 3 |
| Chi | 3 |
| Chad | 3 |
| Border | 3 |
| Box | 3 |
| Bozzette | 3 |
| Building | 3 |
| Bullous | 3 |
| CCL | 3 |
| CD8α | 3 |
| CEA | 3 |
| CFA | 3 |
| CHV | 3 |
| CHV-1 | 3 |
| CIs | 3 |
| CTD | 3 |
| CUA | 3 |
| Candida | 3 |
| Cell | 3 |
| Centres | 3 |
| Mark | 3 |
| Adult | 3 |
| Maurice | 3 |
| Year | 3 |
| WA | 3 |
| Walter | 3 |
| Ward | 3 |
| Wittman | 3 |
| Workshop | 3 |
| Wright | 3 |
| Xiang | 3 |
| Yan | 3 |
| Yersin | 3 |
| Von | 3 |
| Yersinia | 3 |
| Zambia | 3 |
| Zika | 3 |
| Zoster | 3 |
| Zurich | 3 |
| adenovirus-1 | 3 |
| administration | 3 |
| anti | 3 |
| W | 3 |
| Vietnam | 3 |
| Status | 3 |
| Takashi | 3 |
| Supply | 3 |
| Surveys | 3 |
| Sweden | 3 |
| Szucs | 3 |
| TBE | 3 |
| TH | 3 |
| TNF | 3 |
| TX | 3 |
| Textbook | 3 |
| Veterinarians | 3 |
| Training | 3 |
| Treatment | 3 |
| Tunisia | 3 |
| URI | 3 |
| Universal | 3 |
| Vaccinology | 3 |
| Vaxxed | 3 |
| Vet | 3 |
| committee | 3 |
| concanavalin | 3 |
| da | 3 |
| united | 3 |
| pH | 3 |
| parainfluenza-3 | 3 |
| politiques | 3 |
| prevention | 3 |
| publique | 3 |
| sa | 3 |
| services | 3 |
| travailleurs | 3 |
| vaccine | 3 |
| defensins | 3 |
| vacinal | 3 |
| vivo | 3 |
| von | 3 |
| ∧ | 3 |
| ∨ | 3 |
| ␣ | 3 |
|  | 3 |
| Member | 3 |
| obligatoire | 3 |
| neoantigen | 3 |
| mumpsrubella | 3 |
| monophosphoryl | 3 |
| der | 3 |
| dermatomyositis | 3 |
| di¡erent | 3 |
| dy | 3 |
| fibrosarcomas | 3 |
| h1n1 | 3 |
| herpesvirus-1 | 3 |
| herpesvirus-6 | 3 |
| i | 3 |
| il8 | 3 |
| immunoassays | 3 |
| infl | 3 |
| italy | 3 |
| key | 3 |
| les | 3 |
| lo | 3 |
| medicine | 3 |
| Student | 3 |
| fibrosarcoma | 3 |
| StataCorp | 3 |
| Pan | 3 |
| P<0 | 3 |
| PAN | 3 |
| PCV | 3 |
| PRISMA | 3 |
| PUREVAX | 3 |
| PVS | 3 |
| Pakistan | 3 |
| Palestine | 3 |
| Parental | 3 |
| Oseltamivir | 3 |
| Park | 3 |
| Parvovirus | 3 |
| Pasteurella | 3 |
| Pathogenesis | 3 |
| Pathology | 3 |
| Perceptions | 3 |
| Pertussis | 3 |
| Phase | 3 |
| Ottawa | 3 |
| Oral | 3 |
| Plus | 3 |
| N | 3 |
| Mercury | 3 |
| Stata | 3 |
| Meschede | 3 |
| Methodology | 3 |
| Miller | 3 |
| Ministries | 3 |
| Monte | 3 |
| Mortality | 3 |
| N. | 3 |
| Novartis | 3 |
| NIP | 3 |
| NP | 3 |
| NVPO | 3 |
| NW | 3 |
| Narcolepsy | 3 |
| Nations | 3 |
| Nature | 3 |
| Nephrology | 3 |
| Plague | 3 |
| O. | 3 |
| Pocheon | 3 |
| Self | 3 |
| SAE | 3 |
| SDNS | 3 |
| SEM | 3 |
| SH | 3 |
| SHEA | 3 |
| SN | 3 |
| SZ | 3 |
| Sci | 3 |
| Series | 3 |
| Russian | 3 |
| Serum | 3 |
| Shibasaburo | 3 |
| Shuichi | 3 |
| Sigma | 3 |
| Soc | 3 |
| Poland | 3 |
| Southern | 3 |
| Soviet | 3 |
| S1 | 3 |
| Sato | 3 |
| Rubini | 3 |
| Rab | 3 |
| Power | 3 |
| Pract | 3 |
| Portugal | 3 |
| President | 3 |
| QL | 3 |
| RB51 | 3 |
| RIT | 3 |
| RTX | 3 |
| Queensland | 3 |
| Register | 3 |
| Remote | 3 |
| Royal | 3 |
| Res | 3 |
| Reviews | 3 |
| Readying | 3 |
| RotaShield | 3 |
| Rotavirus | 3 |
| IgE | 2 |
| IRB | 2 |
| IM | 2 |
| IMEMR | 2 |
| IMI | 2 |
| ISG | 2 |
| ISCOMs | 2 |
| IU | 2 |
| Ig | 2 |
| IL-1 | 2 |
| IL-17 | 2 |
| Hypersensitivity | 2 |
| IIS | 2 |
| IHN | 2 |
| ICU | 2 |
| IBSS | 2 |
| IAVI | 2 |
| I.m | 2 |
| House | 2 |
| Hygiene | 2 |
| Humoral | 2 |
| Horzinek | 2 |
| Ileal | 2 |
| IgG. | 2 |
| Intervet | 2 |
| Immunise | 2 |
| Inoculation | 2 |
| Ivory | 2 |
| Holohuman | 2 |
| Items | 2 |
| Isolation | 2 |
| Iselin | 2 |
| Ipsos | 2 |
| Interventions | 2 |
| Interferon | 2 |
| Inter | 2 |
| Int | 2 |
| Innovation | 2 |
| Immunodeficiency | 2 |
| Innate | 2 |
| Indiana | 2 |
| Independent | 2 |
| Incident | 2 |
| Inc | 2 |
| Imunizações | 2 |
| Impfkommission | 2 |
| Immunotherapy | 2 |
| Immunosuppression | 2 |
| Immunopathology | 2 |
| Hopkins | 2 |
| Game | 2 |
| Historic | 2 |
| Hispanics | 2 |
| Greater | 2 |
| GraphPad | 2 |
| 2 | |
| Gloucester | 2 |
| Gina | 2 |
| Giardia | 2 |
| Giant | 2 |
| German | 2 |
| Germ | 2 |
| Generation | 2 |
| Gene | 2 |
| Gazette | 2 |
| Gates | 2 |
| Gambia | 2 |
| GSK | 2 |
| G20 | 2 |
| Future | 2 |
| Frontline | 2 |
| Free | 2 |
| Forestry | 2 |
| Focus | 2 |
| Flores | 2 |
| JC | 2 |
| Greene | 2 |
| Greyhound | 2 |
| Grit | 2 |
| Harvard | 2 |
| Hippocrates | 2 |
| Himathongkam | 2 |
| Hideo | 2 |
| Herpesvirus | 2 |
| Herd | 2 |
| Hematopoietic | 2 |
| Hemagglutination | 2 |
| Heidi | 2 |
| Hedrick | 2 |
| HbOC | 2 |
| Hampson | 2 |
| Guidance | 2 |
| Hall | 2 |
| HZV | 2 |
| HSCT | 2 |
| HPV-77 | 2 |
| HIV-1 | 2 |
| HICPAC | 2 |
| HDN | 2 |
| HB | 2 |
| H7N9 | 2 |
| H1N1v | 2 |
| Ixodes | 2 |
| Moore | 2 |
| JE | 2 |
| JL5 | 2 |
| Minister | 2 |
| Miniature | 2 |
| Mie | 2 |
| Microbiology | 2 |
| Michigan | 2 |
| Metropolitan | 2 |
| Mental | 2 |
| Melinda | 2 |
| Melbourne | 2 |
| Meditation | 2 |
| Measurement | 2 |
| McVey | 2 |
| Matthew | 2 |
| Mather | 2 |
| Mastro | 2 |
| Mass | 2 |
| Masaaki | 2 |
| Mary | 2 |
| Mann | 2 |
| Maitland | 2 |
| Maintenance | 2 |
| Macrophagic | 2 |
| Machakos | 2 |
| Mission | 2 |
| Miyamoto | 2 |
| MoVac | 2 |
| Muthén | 2 |
| NK | 2 |
| NIMR | 2 |
| NIAID | 2 |
| NHMRC | 2 |
| NHIS | 2 |
| NGOs | 2 |
| NFκB | 2 |
| NCBI | 2 |
| N-100 | 2 |
| N'Djaména | 2 |
| Murray | 2 |
| Mobile | 2 |
| Multicenter | 2 |
| Mother | 2 |
| Mosier | 2 |
| Morino | 2 |
| Mori | 2 |
| Morgan | 2 |
| Figs | 2 |
| Modern | 2 |
| Models | 2 |
| Mochizuki | 2 |
| Machado | 2 |
| MOG | 2 |
| MMR2 | 2 |
| Kam | 2 |
| Koshida | 2 |
| Kollaritsch | 2 |
| Kivu | 2 |
| Kindergarten | 2 |
| Kimman | 2 |
| Kidasado | 2 |
| Key | 2 |
| Kenji | 2 |
| Keiko | 2 |
| Kaplan | 2 |
| KS | 2 |
| L1 | 2 |
| KD | 2 |
| Jurisprudence | 2 |
| Juhar | 2 |
| Joseph | 2 |
| Jo | 2 |
| Jin | 2 |
| Jeff | 2 |
| Jean | 2 |
| Jane | 2 |
| Jaime | 2 |
| Krakowka | 2 |
| LILACS | 2 |
| MM | 2 |
| Loebermann | 2 |
| MEDLINE | 2 |
| MCV4 | 2 |
| MC | 2 |
| MAS | 2 |
| Lyssavirus | 2 |
| Lymphocyte | 2 |
| Luxembourg | 2 |
| Lupus | 2 |
| Lung | 2 |
| Loehr | 2 |
| Live | 2 |
| Labor | 2 |
| Library | 2 |
| Li | 2 |
| Level | 2 |
| Leukemia | 2 |
| Leica | 2 |
| Laura | 2 |
| Latin | 2 |
| Larson | 2 |
| Lanka | 2 |
| Labrador | 2 |
| Finance | 2 |
| Collie | 2 |
| Feng | 2 |
| Feldman | 2 |
| Boxberger | 2 |
| Boston | 2 |
| Blumberg | 2 |
| Blank | 2 |
| Bioterrorism | 2 |
| Biotechnological | 2 |
| Bio | 2 |
| Better | 2 |
| Benefit | 2 |
| Benefi | 2 |
| Beliefs | 2 |
| Belief | 2 |
| Bayesian | 2 |
| Bayer | 2 |
| Bank | 2 |
| Baker | 2 |
| Background | 2 |
| Bachelor | 2 |
| BVD | 2 |
| BNP | 2 |
| BJC | 2 |
| BEACH | 2 |
| BALB | 2 |
| Boylston | 2 |
| Brasileira | 2 |
| Brian | 2 |
| CTH | 2 |
| Cervarix | 2 |
| Causality | 2 |
| Catalonia | 2 |
| Cary | 2 |
| Carmichael | 2 |
| Capitol | 2 |
| Capital | 2 |
| Cancer | 2 |
| Campylobacter | 2 |
| CUR | 2 |
| CSL | 2 |
| Brief | 2 |
| CK12 | 2 |
| CINAHL | 2 |
| CFU | 2 |
| CFI | 2 |
| CDCYNERGY | 2 |
| CD40 | 2 |
| CD19 | 2 |
| CAV-2 | 2 |
| Bush | 2 |
| Bureau | 2 |
| B.C. | 2 |
| Awareness | 2 |
| Attacks | 2 |
| AJ | 2 |
| Acute | 2 |
| Acceptability | 2 |
| Ababa | 2 |
| Aase | 2 |
| ASO3-adjuvanted | 2 |
| ASE | 2 |
| AS04 | 2 |
| AP | 2 |
| ANCA | 2 |
| AMP | 2 |
| ADV | 2 |
| Additive | 2 |
| AC | 2 |
| A(H1N1)v | 2 |
| A(H1N1)pdm09 | 2 |
| 2f | 2 |
| 2GPI | 2 |
| 18C | 2 |
| 17D | 2 |
| -United | 2 |
| -No | 2 |
| Nakano | 2 |
| Addis | 2 |
| Adenoviridae | 2 |
| Atlantic | 2 |
| Amsterdam | 2 |
| Asians | 2 |
| Ashwell | 2 |
| Army | 2 |
| Argentina | 2 |
| Arai | 2 |
| Apr | 2 |
| Approaches | 2 |
| Approach | 2 |
| Applied | 2 |
| Andrews | 2 |
| Amish | 2 |
| Adjuvant | 2 |
| Amanna | 2 |
| Alexandre | 2 |
| Alex | 2 |
| Al | 2 |
| AgroSciences | 2 |
| Agricultural | 2 |
| Ageing | 2 |
| Aged | 2 |
| Advantix | 2 |
| Administrator | 2 |
| Challenge | 2 |
| Chams | 2 |
| Chan | 2 |
| Dynamics | 2 |
| Ehrlich | 2 |
| Eff | 2 |
| Edmonston | 2 |
| Edmond | 2 |
| ELECTRONIC | 2 |
| EID | 2 |
| EHS | 2 |
| EEA | 2 |
| EDTA | 2 |
| EAE | 2 |
| Duty | 2 |
| Emerging | 2 |
| Drugs | 2 |
| Dow | 2 |
| Douglas | 2 |
| Donne | 2 |
| Doctor | 2 |
| Doberman | 2 |
| Distemper | 2 |
| Disparities | 2 |
| Directorate | 2 |
| Diphtheria | 2 |
| Ejnar | 2 |
| Emile | 2 |
| Di | 2 |
| EudraVigilance | 2 |
| FISS | 2 |
| External | 2 |
| Expenditure | 2 |
| Expectancy | 2 |
| Exp | 2 |
| Exemptions | 2 |
| Executive | 2 |
| Excellence | 2 |
| Evans | 2 |
| EuroMOMO | 2 |
| Ettinger | 2 |
| EndNote | 2 |
| Etiopathogenesis | 2 |
| Ethnicity | 2 |
| Ethiopia | 2 |
| Ethical | 2 |
| Estonia | 2 |
| Eskimo | 2 |
| Epidemiol | 2 |
| Epidemic | 2 |
| Environ | 2 |
| Enrolled | 2 |
| Dilemma | 2 |
| Developed | 2 |
| Characteristics | 2 |
| Clover | 2 |
| Conceptualization | 2 |
| Compulsory | 2 |
| Compensation | 2 |
| Communications | 2 |
| Columbia | 2 |
| Cognitive | 2 |
| Cochrane | 2 |
| Coast | 2 |
| Coalition | 2 |
| Cluster | 2 |
| Clinics | 2 |
| Conjugate | 2 |
| Cleaveland | 2 |
| Classic | 2 |
| Class | 2 |
| Citizens | 2 |
| Childress | 2 |
| Chihuahuas | 2 |
| Chicago | 2 |
| Chen | 2 |
| Chemokines | 2 |
| Charles | 2 |
| Conditions | 2 |
| Conservation | 2 |
| Determinants | 2 |
| DGP | 2 |
| Departments | 2 |
| Decision | 2 |
| Deborah | 2 |
| Davidovitch | 2 |
| David | 2 |
| Danish | 2 |
| Daniel | 2 |
| Daily | 2 |
| Dachshund | 2 |
| DTH | 2 |
| DA | 2 |
| Core | 2 |
| Crupi | 2 |
| Crotalus | 2 |
| Crotalidae | 2 |
| Crohn | 2 |
| Covid | 2 |
| Course | 2 |
| County | 2 |
| Coulter | 2 |
| Correlation | 2 |
| Coronaviruses | 2 |
| NYT | 2 |
| IBD | 2 |
| Nancy | 2 |
| guerin | 2 |
| autoinflammatory | 2 |
| autoantibody | 2 |
| arthralgia | 2 |
| ariate | 2 |
| antigenemia | 2 |
| ani | 2 |
| anguillarum | 2 |
| andβ | 2 |
| alysis | 2 |
| alastrim | 2 |
| adversaires | 2 |
| adenoviral | 2 |
| acidophil | 2 |
| _ | 2 |
| Zrzavy | 2 |
| Zhang | 2 |
| Zettl | 2 |
| Zealanders | 2 |
| Zarkower | 2 |
| Yupik | 2 |
| Yuka | 2 |
| Yuheng | 2 |
| YouTube | 2 |
| bacteriology | 2 |
| beta-1a | 2 |
| board | 2 |
| du | 2 |
| greece | 2 |
| goat | 2 |
| general | 2 |
| fi | 2 |
| fenbendazole | 2 |
| e⁄cacy | 2 |
| epitope(s | 2 |
| ed | 2 |
| ectiveness | 2 |
| débat | 2 |
| doi.org/10.7774/cevr.2012.1.1.3 | 2 |
| borreliosis | 2 |
| desafios | 2 |
| dana | 2 |
| dTpa | 2 |
| cpm | 2 |
| coryza | 2 |
| cat | 2 |
| cal | 2 |
| cacy | 2 |
| ca | 2 |
| bw | 2 |
| Yoshinori | 2 |
| Yokomichi | 2 |
| Yamagata | 2 |
| Typhoid | 2 |
| VAX | 2 |
| VACV | 2 |
| VAAE | 2 |
| Uwe | 2 |
| Update | 2 |
| Unit | 2 |
| Understanding | 2 |
| USD | 2 |
| USA06 | 2 |
| UN | 2 |
| Tuskegee | 2 |
| VFR | 2 |
| Turks | 2 |
| Tuberculosis | 2 |
| Toxoid | 2 |
| Top | 2 |
| Toll | 2 |
| Three | 2 |
| Therapy | 2 |
| Theories | 2 |
| Theiler | 2 |
| Thai | 2 |
| VFC | 2 |
| VMRD | 2 |
| Y | 2 |
| Weimaraner | 2 |
| X | 2 |
| Worth | 2 |
| Worker | 2 |
| Winkelmann | 2 |
| Wimmer | 2 |
| Wilson | 2 |
| William | 2 |
| Wilkie | 2 |
| Weller | 2 |
| Weiss | 2 |
| Web | 2 |
| VP7 | 2 |
| WWTL | 2 |
| WRAIR | 2 |
| WIC | 2 |
| W. | 2 |
| Virology | 2 |
| Virbac | 2 |
| Victor | 2 |
| Version | 2 |
| Variolation | 2 |
| Vaccinated | 2 |
| grippotyphosa | 2 |
| haemagglutinin | 2 |
| Texas | 2 |
| heath | 2 |
| speci¢c | 2 |
| specifi | 2 |
| spain | 2 |
| serovar | 2 |
| serologic | 2 |
| serogroup | 2 |
| selfefficacy | 2 |
| saúde | 2 |
| santé | 2 |
| safety | 2 |
| s12889 | 2 |
| s10157 | 2 |
| rheumatica | 2 |
| review | 2 |
| reovirus | 2 |
| reliability | 2 |
| rater | 2 |
| rainbow | 2 |
| rRabies | 2 |
| queens | 2 |
| quantifi | 2 |
| quand | 2 |
| qPCR | 2 |
| spf | 2 |
| st | 2 |
| states | 2 |
| à | 2 |
| ≥65 | 2 |
| Native | 2 |
| ≥5 | 2 |
| ≥3 | 2 |
| ≥15 | 2 |
| −80 | 2 |
| ↓↑ | 2 |
| ↓ | 2 |
| μ | 2 |
| α | 2 |
| xdrus | 2 |
| swine | 2 |
| varicella | 2 |
| vaccinees | 2 |
| vaccinatum | 2 |
| un | 2 |
| thrombocytopaenic | 2 |
| tgfb | 2 |
| temporal | 2 |
| tarsus | 2 |
| tandis | 2 |
| syndrome | 2 |
| purpura | 2 |
| psittaci | 2 |
| pristane | 2 |
| influenzalike | 2 |
| meningitidis | 2 |
| megalotis | 2 |
| medicare | 2 |
| lto | 2 |
| l'efficacité | 2 |
| kong | 2 |
| kirschneri | 2 |
| journal | 2 |
| j.1750 | 2 |
| interrogans | 2 |
| inflammasome | 2 |
| methotrexate | 2 |
| individuels | 2 |
| imidacloprid | 2 |
| il6 | 2 |
| il | 2 |
| i.p | 2 |
| hydranencephaly | 2 |
| https://doi.org/10.1101/2020.06.03.20121624 | 2 |
| https://doi.org/10.1016/j.vaccine.2020.08.010 | 2 |
| hong | 2 |
| hemagglutininneuraminidase | 2 |
| methoprene | 2 |
| ministry | 2 |
| pomona | 2 |
| occupational | 2 |
| polymyalgia | 2 |
| polyangiitis | 2 |
| polio | 2 |
| pneumonic | 2 |
| permethrin | 2 |
| pemphigus | 2 |
| paratyphoid | 2 |
| pRisk | 2 |
| ou | 2 |
| omdb-2 | 2 |
| objectifs | 2 |
| monkeypox | 2 |
| nucleoprotein | 2 |
| novirhabdoviruses | 2 |
| nonvaccinated | 2 |
| nodosa | 2 |
| na | 2 |
| myopericarditis | 2 |
| myofasciitis | 2 |
| myelitis | 2 |
| murid | 2 |
| multicentre | 2 |
| Th2 | 2 |
| → | 2 |
| Tetravalent | 2 |
| Recombinant | 2 |
| Proc | 2 |
| Prize | 2 |
| Priorix | 2 |
| Principles | 2 |
| Principle | 2 |
| Preventic | 2 |
| Preparedness | 2 |
| Pregshure | 2 |
| Preferred | 2 |
| Pre | 2 |
| Poulet | 2 |
| Population | 2 |
| Poor | 2 |
| Polymerase | 2 |
| Poliomyelitis | 2 |
| Policies | 2 |
| Pneumocystis | 2 |
| Pneu | 2 |
| Plotkin | 2 |
| Plant | 2 |
| Pinschers | 2 |
| Phipps | 2 |
| Philippines | 2 |
| Processes | 2 |
| Progress | 2 |
| Protocol | 2 |
| R.M. | 2 |
| Rattlesnake | 2 |
| Rainbow | 2 |
| Raina | 2 |
| Racing | 2 |
| RSV | 2 |
| RRV | 2 |
| RRMA | 2 |
| RPM1 | 2 |
| RMSEA | 2 |
| RF | 2 |
| Questionnaire | 2 |
| Provision | 2 |
| Quedgeley | 2 |
| Qual | 2 |
| Quadrivalent | 2 |
| Qiagen | 2 |
| QGIS | 2 |
| Q | 2 |
| Pylori | 2 |
| Publisher | 2 |
| Publicity | 2 |
| PsycINFO | 2 |
| Pharmacovigilance | 2 |
| Pharma | 2 |
| Pfizer | 2 |
| Notifiable | 2 |
| Opinion | 2 |
| Onset | 2 |
| Omer | 2 |
| Okuno | 2 |
| Occupational | 2 |
| Obstructive | 2 |
| Objective | 2 |
| OR2.67 | 2 |
| OIV | 2 |
| Nuffield | 2 |
| Note | 2 |
| Orenstein | 2 |
| Norms | 2 |
| Nonmedical | 2 |
| Nobel | 2 |
| Nile | 2 |
| Nielsen | 2 |
| Ng | 2 |
| Neonatal | 2 |
| Test | 2 |
| Natural | 2 |
| Necrosis | 2 |
| Optic | 2 |
| Organizational | 2 |
| Perception | 2 |
| Paediatrics | 2 |
| Pennsylvania | 2 |
| Pattern | 2 |
| Patricia | 2 |
| Pathogen | 2 |
| Parks | 2 |
| Parkman | 2 |
| Papillomavirus | 2 |
| Papilloma | 2 |
| Paper | 2 |
| Pandora | 2 |
| PRRs | 2 |
| Organizations | 2 |
| PROSPERO | 2 |
| PP | 2 |
| PNs | 2 |
| PMWS | 2 |
| P | 2 |
| Oxford | 2 |
| Outcomes | 2 |
| Otocyon | 2 |
| OspA | 2 |
| Orthomyxoviridae | 2 |
| Recognition | 2 |
| Niki | 2 |
| Recombivax | 2 |
| Sera | 2 |
| Sub | 2 |
| Stuart | 2 |
| Strategy | 2 |
| Strategic | 2 |
| Strain | 2 |
| Sternberg | 2 |
| Statistics | 2 |
| Statement | 2 |
| Sri | 2 |
| Springer | 2 |
| Spot | 2 |
| Specific | 2 |
| Special | 2 |
| Southeast | 2 |
| Song | 2 |
| Smith | 2 |
| Sjögren | 2 |
| Simulation | 2 |
| Silicone | 2 |
| Shi | 2 |
| Shawnee | 2 |
| Servants | 2 |
| Seroprevalence | 2 |
| Subjects | 2 |
| Surg | 2 |
| Surgeon | 2 |
| Tak | 2 |
| Technologies | 2 |
| Recommendation | 2 |
| Teleost | 2 |
| Taya | 2 |
| Tcell | 2 |
| Taqman | 2 |
| Tanaka | 2 |
| Tamiflu | 2 |
| Takayasu | 2 |
| Takahashi | 2 |
| Tailoring | 2 |
| Surrey | 2 |
| Tables | 2 |
| TTCV | 2 |
| TRA | 2 |
| TLI | 2 |
| TD | 2 |
| T84 | 2 |
| Systemic | 2 |
| Syria | 2 |
| Sydney | 2 |
| Surveying | 2 |
| Sero | 2 |
| Tax | 2 |
| Senate | 2 |
| Rhinoviruses | 2 |
| S19 | 2 |
| Ruth | 2 |
| Russia | 2 |
| Roux | 2 |
| Rottweilers | 2 |
| Rotarix | 2 |
| Ross | 2 |
| Rommer | 2 |
| Rockefeller | 2 |
| Rie | 2 |
| Rhabdoviridae | 2 |
| SEIQR | 2 |
| Rex | 2 |
| Rev. | 2 |
| Restraint | 2 |
| Respir | 2 |
| Repeat | 2 |
| Related | 2 |
| Registry | 2 |
| Reference | 2 |
| Selected | 2 |
| Red | 2 |
| SC | 2 |
| Refusal | 2 |
| SEIR | 2 |
| Saeko | 2 |
| Second | 2 |
| Scott | 2 |
| SIRVA | 2 |
| Scler | 2 |
| Satoru | 2 |
| Satoh | 2 |
| Sarah | 2 |
| Sao | 2 |
| San | 2 |
| Salmo | 2 |
| Redmond | 2 |
| Sadir | 2 |
| Saad | 2 |
| SIVS | 2 |
| SOT | 2 |
| SS | 2 |
| SSc | 2 |
| SIS | 2 |
| SUS | 2 |
| SVEIR | 2 |
| SITR | 2 |
| ICH | 1 |
| IL-21 | 1 |
| IL)-7 | 1 |
| IH | 1 |
| IFPMA | 1 |
| IDF | 1 |
| IDDM | 1 |
| ICOS | 1 |
| IL-2 | 1 |
| ICD | 1 |
| ICD-9/10 | 1 |
| IL-6 | 1 |
| IC31 | 1 |
| IC-12-IC-13 | 1 |
| IC | 1 |
| IAM | 1 |
| IACUC | 1 |
| IA | 1 |
| I.N. | 1 |
| Hyclone | 1 |
| Hutchison | 1 |
| IL-4 | 1 |
| IMPACT | 1 |
| IL-7R | 1 |
| IL1 | 1 |
| Ilan | 1 |
| IgM,,-FITC | 1 |
| IgGc | 1 |
| Hutchinson | 1 |
| IgG1 | 1 |
| IgA. | 1 |
| Ig)E | 1 |
| Ictalurus | 1 |
| Ichthyophthirius | 1 |
| Ich | 1 |
| Ian | 1 |
| IX | 1 |
| IVS | 1 |
| IUD | 1 |
| ISMA | 1 |
| IRIVs | 1 |
| IPINET | 1 |
| IOM | 1 |
| INF | 1 |
| IN- | 1 |
| IL17 | 1 |
| ISGs | 1 |
| Hiroko | 1 |
| Hutchins | 1 |
| Henry | 1 |
| HibMenCY | 1 |
| Hialeah | 1 |
| Hethcote | 1 |
| Heterologous | 1 |
| Herwig | 1 |
| Herpes- | 1 |
| Hernan | 1 |
| Heritage | 1 |
| Herbal | 1 |
| Hepadnaviridae | 1 |
| Henning | 1 |
| Hussein | 1 |
| Henderson | 1 |
| Hematol | 1 |
| Hemagglutinin | 1 |
| Hellenic | 1 |
| Helicobactu | 1 |
| Helene | 1 |
| Hegglin | 1 |
| Hee | 1 |
| Heckert | 1 |
| Heberden | 1 |
| Highlight | 1 |
| Highlights | 1 |
| Highrisk | 1 |
| Hillerød | 1 |
| Hussain | 1 |
| Husband | 1 |
| Hupert | 1 |
| Huntington | 1 |
| Hungary | 1 |
| Hundreds | 1 |
| Humidity | 1 |
| Humans | 1 |
| Humanitarian | 1 |
| Hughes | 1 |
| Huangpu | 1 |
| Huang | 1 |
| Hongkou | 1 |
| Holopatient | 1 |
| Hololens | 1 |
| Holmgren | 1 |
| Holly | 1 |
| Holders | 1 |
| Ho | 1 |
| Histopaque-1077 | 1 |
| Hispanic | 1 |
| Iljeesa | 1 |
| Interaction | 1 |
| Iljong | 1 |
| Ito | 1 |
| JOURNAL | 1 |
| JL-5 | 1 |
| J991 | 1 |
| J44 | 1 |
| J.V.E. | 1 |
| J.V.E | 1 |
| J.S. | 1 |
| J.F. | 1 |
| J.A. | 1 |
| Iwamura | 1 |
| Itasca | 1 |
| Interim | 1 |
| Issue | 1 |
| Ishimori | 1 |
| Ishikura | 1 |
| Isabella | 1 |
| Iringa | 1 |
| Irene | 1 |
| Iran | 1 |
| Invitrogen | 1 |
| Investigational | 1 |
| Interprofessional | 1 |
| Jacobs | 1 |
| Jan | 1 |
| Janeiro | 1 |
| Janesse | 1 |
| Jing'an | 1 |
| Jimenez | 1 |
| Hayut | 1 |
| Jiechen | 1 |
| Jiading | 1 |
| Jeyaseelan | 1 |
| Jews | 1 |
| Jesús | 1 |
| Jesty | 1 |
| Jesse | 1 |
| Jerusalem | 1 |
| Jersey | 1 |
| Jerne | 1 |
| Jeonju | 1 |
| Jeongjo | 1 |
| Jeong | 1 |
| Je | 1 |
| Jaythoon | 1 |
| Javier | 1 |
| Jarrod | 1 |
| Janet | 1 |
| Internalization | 1 |
| Interference | 1 |
| Illn | 1 |
| Immunotherapeutic | 1 |
| In | 1 |
| Imputation | 1 |
| Improvement | 1 |
| Improved | 1 |
| Implicit | 1 |
| Implementation | 1 |
| Impfung | 1 |
| Imperative | 1 |
| Impacts | 1 |
| Imnaunocompetent | 1 |
| Immunopathol | 1 |
| Interfaces | 1 |
| Immunological | 1 |
| Immunocompromised | 1 |
| Immunocompetence | 1 |
| Immunizations | 1 |
| Immunisers | 1 |
| Immnnologic | 1 |
| Immediate | 1 |
| Imm | 1 |
| ImagenH | 1 |
| Illness | 1 |
| Inaya | 1 |
| Inca | 1 |
| Incomplete | 1 |
| Indicators | 1 |
| Interdisciplinary | 1 |
| Intention | 1 |
| Intent | 1 |
| Intensive | 1 |
| Integration | 1 |
| Institut | 1 |
| 1 | |
| Inquiry | 1 |
| Injection | 1 |
| Inhibition | 1 |
| Inglesby | 1 |
| Influenzavaccination | 1 |
| Inflammatory | 1 |
| Inflammasome | 1 |
| Infl | 1 |
| Infektionskrankheiten | 1 |
| Infect | 1 |
| Infantile | 1 |
| Infant | 1 |
| Inf | 1 |
| Industries | 1 |
| Healthypeople.gov | 1 |
| Genetic | 1 |
| Haydon | 1 |
| Funk | 1 |
| GCRV | 1 |
| GCA | 1 |
| GALT | 1 |
| GAD | 1 |
| GABA | 1 |
| G8 | 1 |
| G5 | 1 |
| G.R.G. | 1 |
| Furuya | 1 |
| Furstentum | 1 |
| Funding | 1 |
| Fredrick | 1 |
| Fundamentals | 1 |
| Function | 1 |
| Fukuoka | 1 |
| Fukuda | 1 |
| Fujii | 1 |
| Frost | 1 |
| Friis | 1 |
| Friedman | 1 |
| Friday | 1 |
| Frequencies | 1 |
| GED | 1 |
| GEIG | 1 |
| GFK | 1 |
| GIBCO | 1 |
| Gebert | 1 |
| Geagea | 1 |
| Gaza | 1 |
| Gavi | 1 |
| Gaudino | 1 |
| Gaston | 1 |
| Gardeñes | 1 |
| Gardesil | 1 |
| GardasilReg | 1 |
| Gantt | 1 |
| Ganem | 1 |
| Gamzo | 1 |
| Gallup | 1 |
| Gallagher | 1 |
| Ga | 1 |
| GUIDELINES | 1 |
| GU2 | 1 |
| GROUP | 1 |
| GPA | 1 |
| GK | 1 |
| GIGXR | 1 |
| Freepost | 1 |
| Fred | 1 |
| Havrix | 1 |
| Fendrix | 1 |
| Fisheries | 1 |
| Fischer | 1 |
| Fink | 1 |
| Fingolimod | 1 |
| Fielding | 1 |
| Field | 1 |
| Fibromyalgia | 1 |
| Ferran | 1 |
| Fernandes | 1 |
| Fengxian | 1 |
| Fence | 1 |
| Frankfurt | 1 |
| Fen | 1 |
| Felsburg | 1 |
| Fei | 1 |
| Fedson | 1 |
| Feasibility | 1 |
| Faye | 1 |
| Fax | 1 |
| Father | 1 |
| Johansen | 1 |
| Farhaan | 1 |
| Fit | 1 |
| Flanders | 1 |
| Flavobacterium | 1 |
| Fleiss | 1 |
| Frankenstein | 1 |
| Frank | 1 |
| Francisco | 1 |
| Fourteenth | 1 |
| Fournet | 1 |
| Forms | 1 |
| Forces | 1 |
| Fora | 1 |
| Foot | 1 |
| Follow | 1 |
| Foe | 1 |
| Fluzone | 1 |
| Fluorescent | 1 |
| Flul | 1 |
| Fluenz | 1 |
| Flucelvax | 1 |
| Fluarix | 1 |
| FluMist(R | 1 |
| FluMist | 1 |
| Fletcher | 1 |
| Flemish | 1 |
| Gel | 1 |
| Gender | 1 |
| Genomics | 1 |
| H3N8 | 1 |
| HKU | 1 |
| HHV-6 | 1 |
| HDP | 1 |
| HCV | 1 |
| HCD | 1 |
| HBsAg | 1 |
| HBs | 1 |
| HABIT | 1 |
| HA1 | 1 |
| HA | 1 |
| H3K4 | 1 |
| Genotype | 1 |
| H2N2 | 1 |
| H27 | 1 |
| H20A | 1 |
| H10N8 | 1 |
| H1 | 1 |
| Gómez | 1 |
| Gyrodactylus | 1 |
| Gyrodactylidae | 1 |
| Gyeongsangnamdo | 1 |
| Guze | 1 |
| HLADR14 | 1 |
| HLR | 1 |
| HOD | 1 |
| HPV-16/18 | 1 |
| Hatz | 1 |
| Hassan | 1 |
| Hasan | 1 |
| Harte | 1 |
| Harry | 1 |
| Hantavirus | 1 |
| Hansung | 1 |
| Hankookhakbo | 1 |
| Haney | 1 |